Through five vivid stories of Viking deaths—from ambushes to executions—we uncover how honor, fate, and ferocity defined ...

T ributes have been paid to the "larger than life" chairman of Peel Viking Longboats, Nigel Rawlinson, following his death at ...

Loss per share was $(0.58), falling short of analyst expectations by $(0.13), or 29.1% (GAAP, Q2 2025). - Research and development expenses rose to $60.2 million in Q2 2025, up from $23.8 million in ...

Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...

Investing.com -- Viking Therapeutics, Inc. (NASDAQ: VKTX) reported a wider-than-expected second quarter loss on Wednesday, sending shares down 4.2% as investors reacted to the earnings miss despite ...

Viking Therapeutics, Inc. ( NASDAQ: VKTX) Q2 2025 Earnings Conference Call July 23, 2025 4:30 PM ET Brian Lian - President, CEO & Director Gregory Zante - Chief Financial Officer ...

Eli Lilly is a leader in the weight loss drug market, generating blockbuster revenue. Viking Therapeutics recently launched a ...

Bellanca Viking has wooden wings and fabric covering that hark back to aviation’s golden age, though its performance is ...

On the river voyage, guests will have the opportunity to see Guwahati's temple, search for one-horned rhinos and buffaloes in ...

Seven Viking Global alums have started their own funds in the past three years, with one more on the way. It's an unusual level of launch activity for the industry — raising questions about ...

Viking Therapeutics will launch a longship into phase 3 for the obesity drug VK2735 sooner than expected, with a clinical program expected to top $300 million. The biotech—which was launched ...